FP7: DARTRIX Project

RCL has just been awarded a €600,000 grant as part of a €6 million European Commission project named DARTRIX, headed by Professor Kerry Chester from the Cancer Institute at University College London (UCL). RCL’s responsibilities within the project will be to develop cutting edge magnetic hyperthermia technology for the treatment of glioblastoma, an incurable brain cancer. Starting in 2012, the 7th Framework Programme (FP7) will aim to begin human trials late 2014/early 2015.